Hemostatic changes in patients with end stage renal disease undergoing hemodialysis

被引：38

作者：

Alves Rios, Danyelle Romana ^{[1
]}

Carvalho, Maria das Gracas ^{[1
]}

Lwaleed, Bashir A. ^{[1
]}

Simoes e Silva, Ana Cristina ^{[1
]}

Gomes Borges, Karina Braga ^{[1
]}

SantAna Dusse, Luci Maria ^{[1
]}

机构：

[1] Univ Fed Minas Gerais, Fac Farm, Clin & Toxicol Anal Dept, BR-31270901 Belo Horizonte, MG, Brazil

来源：

CLINICA CHIMICA ACTA | 2010年 / 411卷 / 3-4期

关键词：

Hemodialysis; Coagulation; Fibrinolysis; Platelets; End stage renal disease; VASCULAR ACCESS THROMBOSIS; FACTOR PATHWAY INHIBITOR; ENDOTHELIAL-CELL MARKERS; GLYCOPROTEIN-IIB-IIIA; UREMIC PATIENTS; ARTERIOVENOUS-FISTULA; PLATELET-AGGREGATION; TISSUE FACTOR; MAINTENANCE HEMODIALYSIS; GUANIDINOSUCCINIC ACID;

D O I：

10.1016/j.cca.2009.11.022

中图分类号：

R446 [实验室诊断]; R-33 [实验医学、医学实验];

学科分类号：

1001 ;

摘要：

Patients undergoing hemodialysis may show both thrombotic complications and bleeding abnormalities. Hemostatic changes in patients on hemodialysis may result from alterations in vessel wall integrity and platelet function, and reduced blood flow in the native arteriovenous fistula. Vascular complications represent 20-25% of all hospitalizations of patients on hemodialysis. Literature survey revealed that changes in the hemostatic system may play a major role in vascular complications observed in these patients. Thus, it is essential to investigate hemostatic alterations in patients on hemodialysis so that adequate regimes for anticoagulant therapy could be implemented. In this review we discuss hemostatic abnormalities in end stage renal disease patients undergoing hemodialysis. (c) 2009 Elsevier B.V. All rights reserved.

引用

页码：135 / 139

页数：5

共 78 条

[11] INITIATION OF BLOOD-COAGULATION AT ARTIFICIAL SURFACES [J].